Dopaminergic system genes in ADHD

Toward a biological hypothesis

Aiveen Kirley, Ziarih Hawi, Grainne Daly, Mary McCarron, Celine Mullins, Niamh Millar, Irwin Waldman, Michael Fitzgerald, Michael Gill

Research output: Contribution to journalArticleResearchpeer-review

157 Citations (Scopus)

Abstract

Converging evidence has implicated abnormalities of dopamine neurotransmission to the pathology of attention deficit hyperactivity disorder (ADHD). Several genetic association studies have been published, but so far, no DNA variants have been unequivocally demonstrated as contributing to ADHD susceptibility. Four dopamine related gene loci have been implicated, however: DAT1, DRD4, DBH, and DRD5. Each of these may influence the liability of ADHD to a small degree. Notably, all are involved in signal transduction at the neuronal synapse. In this article, we investigate as candidate genes for ADHD, DNA polymorphisms at dopamine receptors, the dopamine transporter, and genes known to be involved in dopamine synthesis and metabolism. In a recent article, we confirmed the previously reported association of DAT1 (480bp allele) with ADHD and identified polymorphisms at two additional loci showing preferential transmission to ADHD children of alleles at DRD5 (148bp allele) and at DBH (allele 2, Taq I polymorphism). Increased transmission of the 4bp deletion in the untranslated exon 1 of the DOPA decarboxylase gene was also observed but was of marginal significance. Nonsignificant trends of association were found for TH (allele 2) and DRD2 (Ser-311). No preferential transmission of alleles to ADHD children was observed for polymorphisms at DRD1, DRD2 (Taq I), DRD3, DRD4, and COMT. Analyzing the data by sex of transmitting parent showed significant preferential paternal transmission of alleles at TH (allele 2) and a nonsignificant trend for paternal transmission for DRD2 (Ser-311). We attempt to put these findings together with what is known of the function of the particular proteins, and suggest working hypotheses.

Original languageEnglish
Pages (from-to)607-619
Number of pages13
JournalNeuropsychopharmacology
Volume27
Issue number4
DOIs
Publication statusPublished - Oct 2002
Externally publishedYes

Keywords

  • Attention deficit hyperactivity disorder
  • Candidate genes
  • Dopamine receptors
  • Dopamine transporter
  • Haplotype-based haplotype relative risk
  • Imprinting
  • Transmission Disequilibrium Test

Cite this

Kirley, A., Hawi, Z., Daly, G., McCarron, M., Mullins, C., Millar, N., ... Gill, M. (2002). Dopaminergic system genes in ADHD: Toward a biological hypothesis. Neuropsychopharmacology, 27(4), 607-619. https://doi.org/10.1016/S0893-133X(02)00315-9
Kirley, Aiveen ; Hawi, Ziarih ; Daly, Grainne ; McCarron, Mary ; Mullins, Celine ; Millar, Niamh ; Waldman, Irwin ; Fitzgerald, Michael ; Gill, Michael. / Dopaminergic system genes in ADHD : Toward a biological hypothesis. In: Neuropsychopharmacology. 2002 ; Vol. 27, No. 4. pp. 607-619.
@article{fafd621be2d64e17ab789fbc59b993f9,
title = "Dopaminergic system genes in ADHD: Toward a biological hypothesis",
abstract = "Converging evidence has implicated abnormalities of dopamine neurotransmission to the pathology of attention deficit hyperactivity disorder (ADHD). Several genetic association studies have been published, but so far, no DNA variants have been unequivocally demonstrated as contributing to ADHD susceptibility. Four dopamine related gene loci have been implicated, however: DAT1, DRD4, DBH, and DRD5. Each of these may influence the liability of ADHD to a small degree. Notably, all are involved in signal transduction at the neuronal synapse. In this article, we investigate as candidate genes for ADHD, DNA polymorphisms at dopamine receptors, the dopamine transporter, and genes known to be involved in dopamine synthesis and metabolism. In a recent article, we confirmed the previously reported association of DAT1 (480bp allele) with ADHD and identified polymorphisms at two additional loci showing preferential transmission to ADHD children of alleles at DRD5 (148bp allele) and at DBH (allele 2, Taq I polymorphism). Increased transmission of the 4bp deletion in the untranslated exon 1 of the DOPA decarboxylase gene was also observed but was of marginal significance. Nonsignificant trends of association were found for TH (allele 2) and DRD2 (Ser-311). No preferential transmission of alleles to ADHD children was observed for polymorphisms at DRD1, DRD2 (Taq I), DRD3, DRD4, and COMT. Analyzing the data by sex of transmitting parent showed significant preferential paternal transmission of alleles at TH (allele 2) and a nonsignificant trend for paternal transmission for DRD2 (Ser-311). We attempt to put these findings together with what is known of the function of the particular proteins, and suggest working hypotheses.",
keywords = "Attention deficit hyperactivity disorder, Candidate genes, Dopamine receptors, Dopamine transporter, Haplotype-based haplotype relative risk, Imprinting, Transmission Disequilibrium Test",
author = "Aiveen Kirley and Ziarih Hawi and Grainne Daly and Mary McCarron and Celine Mullins and Niamh Millar and Irwin Waldman and Michael Fitzgerald and Michael Gill",
year = "2002",
month = "10",
doi = "10.1016/S0893-133X(02)00315-9",
language = "English",
volume = "27",
pages = "607--619",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "4",

}

Kirley, A, Hawi, Z, Daly, G, McCarron, M, Mullins, C, Millar, N, Waldman, I, Fitzgerald, M & Gill, M 2002, 'Dopaminergic system genes in ADHD: Toward a biological hypothesis', Neuropsychopharmacology, vol. 27, no. 4, pp. 607-619. https://doi.org/10.1016/S0893-133X(02)00315-9

Dopaminergic system genes in ADHD : Toward a biological hypothesis. / Kirley, Aiveen; Hawi, Ziarih; Daly, Grainne; McCarron, Mary; Mullins, Celine; Millar, Niamh; Waldman, Irwin; Fitzgerald, Michael; Gill, Michael.

In: Neuropsychopharmacology, Vol. 27, No. 4, 10.2002, p. 607-619.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Dopaminergic system genes in ADHD

T2 - Toward a biological hypothesis

AU - Kirley, Aiveen

AU - Hawi, Ziarih

AU - Daly, Grainne

AU - McCarron, Mary

AU - Mullins, Celine

AU - Millar, Niamh

AU - Waldman, Irwin

AU - Fitzgerald, Michael

AU - Gill, Michael

PY - 2002/10

Y1 - 2002/10

N2 - Converging evidence has implicated abnormalities of dopamine neurotransmission to the pathology of attention deficit hyperactivity disorder (ADHD). Several genetic association studies have been published, but so far, no DNA variants have been unequivocally demonstrated as contributing to ADHD susceptibility. Four dopamine related gene loci have been implicated, however: DAT1, DRD4, DBH, and DRD5. Each of these may influence the liability of ADHD to a small degree. Notably, all are involved in signal transduction at the neuronal synapse. In this article, we investigate as candidate genes for ADHD, DNA polymorphisms at dopamine receptors, the dopamine transporter, and genes known to be involved in dopamine synthesis and metabolism. In a recent article, we confirmed the previously reported association of DAT1 (480bp allele) with ADHD and identified polymorphisms at two additional loci showing preferential transmission to ADHD children of alleles at DRD5 (148bp allele) and at DBH (allele 2, Taq I polymorphism). Increased transmission of the 4bp deletion in the untranslated exon 1 of the DOPA decarboxylase gene was also observed but was of marginal significance. Nonsignificant trends of association were found for TH (allele 2) and DRD2 (Ser-311). No preferential transmission of alleles to ADHD children was observed for polymorphisms at DRD1, DRD2 (Taq I), DRD3, DRD4, and COMT. Analyzing the data by sex of transmitting parent showed significant preferential paternal transmission of alleles at TH (allele 2) and a nonsignificant trend for paternal transmission for DRD2 (Ser-311). We attempt to put these findings together with what is known of the function of the particular proteins, and suggest working hypotheses.

AB - Converging evidence has implicated abnormalities of dopamine neurotransmission to the pathology of attention deficit hyperactivity disorder (ADHD). Several genetic association studies have been published, but so far, no DNA variants have been unequivocally demonstrated as contributing to ADHD susceptibility. Four dopamine related gene loci have been implicated, however: DAT1, DRD4, DBH, and DRD5. Each of these may influence the liability of ADHD to a small degree. Notably, all are involved in signal transduction at the neuronal synapse. In this article, we investigate as candidate genes for ADHD, DNA polymorphisms at dopamine receptors, the dopamine transporter, and genes known to be involved in dopamine synthesis and metabolism. In a recent article, we confirmed the previously reported association of DAT1 (480bp allele) with ADHD and identified polymorphisms at two additional loci showing preferential transmission to ADHD children of alleles at DRD5 (148bp allele) and at DBH (allele 2, Taq I polymorphism). Increased transmission of the 4bp deletion in the untranslated exon 1 of the DOPA decarboxylase gene was also observed but was of marginal significance. Nonsignificant trends of association were found for TH (allele 2) and DRD2 (Ser-311). No preferential transmission of alleles to ADHD children was observed for polymorphisms at DRD1, DRD2 (Taq I), DRD3, DRD4, and COMT. Analyzing the data by sex of transmitting parent showed significant preferential paternal transmission of alleles at TH (allele 2) and a nonsignificant trend for paternal transmission for DRD2 (Ser-311). We attempt to put these findings together with what is known of the function of the particular proteins, and suggest working hypotheses.

KW - Attention deficit hyperactivity disorder

KW - Candidate genes

KW - Dopamine receptors

KW - Dopamine transporter

KW - Haplotype-based haplotype relative risk

KW - Imprinting

KW - Transmission Disequilibrium Test

UR - http://www.scopus.com/inward/record.url?scp=0036788707&partnerID=8YFLogxK

U2 - 10.1016/S0893-133X(02)00315-9

DO - 10.1016/S0893-133X(02)00315-9

M3 - Article

VL - 27

SP - 607

EP - 619

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 4

ER -